3Semana·

Eli Lilly issues statement: LILLY HAS 'NO AFFILIATION' WITH HIMS

$HIMS (+4,08 %)
$LLY (+3,93 %)
$NOVO B (+1,43 %)

BamBamInvest

@BamBamInvest

3Semana·

BREAKING: Bloomberg reports that HIMS is partnering with Lilly to sell Zepbound through its telehealth platform 🚀

$HIMS (+4,08 %)
$LLY (+3,93 %)
$NOVO B (+1,43 %)

6 Comentarios

~ S.@Semos25

3Semana

Oh the name 🥲

•

BamBamInvest@BamBamInvest

3Semana

@Semos25 wait and see what exactly this means or what purpose it serves. All free advertising if $HIMS becomes more and more the focus 😁 Wouldn't immediately call that a bad thing. That said, this is not and never has been the main source of revenue.

••

Memo0606@Memo0606

3Semana

@BamBamInvest if you owned novo and hims
it would make sense for you to switch into hims and sell novo at the moment

••

BamBamInvest@BamBamInvest

3Semana

@Memo0606 I don't see either of these as bad investments. It all depends on your investment strategy. I just see more potential with $HIMS over 5+ years in terms of the risk/reward ratio. $NOVO B is more value, as you can't predict how the tariffs and US business will continue. As you can easily see from my portfolio, I am betting more on growth or where I think I can make 10x over 5-10 years.

•

Memo0606@Memo0606

3Semana

@BamBamInvest understand your point
what speaks in favor of a reallocation for me is that I then reduce my positions in my portfolio
but I am easily 30% down on novo... I'll wait and see

•

Ph1l1pp@Ph1l1pp

3Semana

😂🦍

••